Amneal Pharmaceuticals (AMRX) Income After Tax (2017 - 2026)
Amneal Pharmaceuticals' Income After Tax was $12.31 million in Q3 2026, down 32.1% from $18.13 million a year earlier and down 82.3% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Income After Tax (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amneal Pharmaceuticals' Income After Tax was $209.49 million through Sep 30, 2026, up 263.6% year-over-year; for FY2025, it was $127.93 million.
- Income After Tax shows a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- In earlier years, Income After Tax was -$73.88 million in FY2024, -$48.72 million in FY2023, -$254.83 million in FY2022 and $20.17 million in FY2021 (-70.6%).
- The Q3 2026 figure marks the lowest quarterly Income After Tax since Q4 2024.
- Compared with a year earlier, Income After Tax was higher in four of the last five quarters, with growth averaging 89.3%.
- Per Business Quant data, AMRX's Income After Tax in the three quarters before Q3 2026 was $69.61 million (Q2 2026), $78 million (Q1 2026) and $49.57 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Amneal Pharmaceuticals | 7.10 Bn | 6.33 Bn | 334.12 Mn | 12.31 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.31 Mn |
| Jun 30, 2026 | 69.61 Mn |
| Mar 31, 2026 | 78.00 Mn |
| Dec 31, 2025 | 49.57 Mn |
| Sep 30, 2025 | 18.13 Mn |
| Jun 30, 2025 | 35.61 Mn |
| Mar 31, 2025 | 24.62 Mn |
| Dec 31, 2024 | -20.74 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 16.79 Mn |
| Mar 31, 2024 | -81.68 Mn |
| Dec 31, 2023 | -93.34 Mn |
| Sep 30, 2023 | 25.06 Mn |
| Jun 30, 2023 | 29.68 Mn |
| Mar 31, 2023 | -10.13 Mn |
| Dec 31, 2022 | -5.86 Mn |
| Sep 30, 2022 | -2.42 Mn |
| Jun 30, 2022 | -240.13 Mn |
| Mar 31, 2022 | -6.42 Mn |
| Dec 31, 2021 | -20.42 Mn |
Amneal Pharmaceuticals Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();